Related references
Note: Only part of the references are listed.Immunogenicity of long-lasting recombinant factor VIII products
Mathieu Ing et al.
CELLULAR IMMUNOLOGY (2016)
Butyrylcholinesterase nanocapsule as a long circulating bioscavenger with reduced immune response
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Immunogenicity of Therapeutic Protein Aggregates
Ehab M. Moussa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Chemical conjugation of zwitterionic polymers protects immunogenic enzyme and preserves bioactivity without polymer-specific antibody response
Sijun Liu et al.
Nano Today (2016)
Therapeutic outcomes, assessments, risk factors and mitigation efforts of immunogenicity of therapeutic protein products
Liusong Yin et al.
CELLULAR IMMUNOLOGY (2015)
Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity
Peng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Animal model of acute gout reproduces the inflammatory and ultrasonographic joint changes of human gout
Carlos Pineda et al.
ARTHRITIS RESEARCH & THERAPY (2015)
What's fueling the biotech engine-2012 to 2013
Saurabh Rob Aggarwal
NATURE BIOTECHNOLOGY (2014)
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
Michael S. Hershfield et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
Peter E. Lipsky et al.
ARTHRITIS RESEARCH & THERAPY (2014)
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
Vibha Jawa et al.
CLINICAL IMMUNOLOGY (2013)
Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats
Rosane M. S. dos Santos et al.
INFLAMMATION RESEARCH (2013)
Zwitterionic hydrogels implanted in mice resist the foreign-body reaction
Lei Zhang et al.
NATURE BIOTECHNOLOGY (2013)
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
Pauline A. van Schouwenburg et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Narendra Chirmule et al.
AAPS JOURNAL (2012)
The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon
Sanna Rosengren et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity
Andrew J. Keefe et al.
NATURE CHEMISTRY (2012)
Uniform zwitterionic polymer hydrogels with a nonfouling and functionalizable crosslinker using photopolymerization
Louisa R. Carr et al.
BIOMATERIALS (2011)
Pegloticase and Chronic Gout Reply
John S. Sundy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Ultralow-Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications
Shaoyi Jiang et al.
ADVANCED MATERIALS (2010)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Immunogenicity of therapeutics: a matter of efficacy and safety
Andreas Nechansky et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse
S. S. Glasson et al.
OSTEOARTHRITIS AND CARTILAGE (2010)
High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals
Anna Scanu et al.
ARTHRITIS RESEARCH & THERAPY (2010)
T-Cell Activation by Antigen-Loaded pH-Sensitive Hydrogel Particles in Vivo: The Effect of Particle Size
Joel A. Cohen et al.
BIOCONJUGATE CHEMISTRY (2009)
Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma
Jon Ladd et al.
BIOMACROMOLECULES (2008)
CD54 is a surrogate marker of antigen presenting cell activation
N. A. Sheikh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C
AA van der Eijk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
NJ Ganson et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Share Paper
